PDCD1 and cancer: In cancer treatment, novel therapeutic approaches such as CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), Cre/Lox gene editing, and immunotherapies like CAR-T and PD-1/PD-L1 inhibitors have emerged, yet they come with their challenges.